DM
Diabetic Ketoacidosis Management in Children
search
Diabetic Ketoacidosis Management in Children
, Pediatric DKA Treatment
See Also
Diabetic Ketoacidosis
Diabetic Ketoacidosis Management in Adults
Diabetic Ketoacidosis in Pregnancy
Diabetic Ketoacidosis Related Cerebral Edema
Diabetes Mellitus
Type I Diabetes Mellitus
Type II Diabetes Mellitus
Insulin Resistance Syndrome
Glucose Metabolism
Diabetes Mellitus Education
Diabetes Mellitus Complications
Diabetic Ketoacidosis
Hyperosmolar Hyperglycemic State
Diabetes Mellitus Control in Hospital
Diabetes Mellitus Glucose Management
Hypertension in Diabetes Mellitus
Hyperlipidemia in Diabetes Mellitus
Diabetic Retinopathy
Diabetic Nephropathy
Diabetic Neuropathy
Management
Phase 1 - Fluids in Children (Emergent)
Stabilize shock and
Coma
states first!
Children with DKA present with at least 5 to 10%
Dehydration
Correct Volume Deficit
Initial
Give 10-20 cc/kg NS bolus over first 45 minutes
Both 10 and 20 cc/kg bolus are safe with similar outcomes
Pruitt (2019) Am J Emerg Med 37(12): 2239-41 [PubMed]
Kuppermann (2018) N Engl J Med 378(24):2275-87 +PMID: 29897851 [PubMed]
Repeat fluid bolus until shock corrected
Next
Fluid deficit replacement distributed evenly over 48 hour period
Start with NS and may continue with NS (or transition to 1/2 NS over the subsequent 8-10 hours)
Normal Saline
(NS) is often continued as maintenance fluid to prevent
Hyponatremia
with 1/2NS
Rate: 5 ml/kg/hour (1.5 times maintenance)
Use fluids without dextrose (NS or 1/2NS) until
Serum Glucose
<250 mg/dl, then use D5 NS or D51/2NS
In children, Dextrose may be added to fluid starting at
Serum Glucose
<300 mg/dl
Precautions
Follow Intake and output closely
Do not drop
Serum Osmolality
(calculated) >3 mOsms/hour
See
Diabetic Ketoacidosis Related Cerebral Edema
Suspected cerebral edema requires emergent management
Speed of IV hydration as a cerebral edema cause is controversial (debunked in at least one study)
Slow replacement if
Fluid Overload
risk (and consider close hemodynamic monitoring)
Congestive Heart Failure
Chronic Renal Insufficiency
Management
Phase 2 - Acidosis,
Electrolyte
s in children
Potassium Replacement
Precautions
Hypokalemia
must be corrected prior to
Insulin
Hold
Insulin
until
Potassium
>2.5 meq/L in children
Prerequisites
Electrocardiogram
without signs of
Hyperkalemia
Adequate
Urine Output
Administration: Children
Serum Potassium
<2.5 meq/L
Do not administer
Insulin
until
Potassium
>2.5 meq/L
KCl 1 meq/kg (to 40 meq) IV over 1 hour, recheck
This is maximum IV
Potassium
rate!
Requires cardiac monitoring
Requires hourly recheck of
Serum Potassium
Serum Potassium
2.5 to 3.5 meq/L
Give 40-60 meq/L in IV solution
Recheck
Serum Potassium
hourly
Continue replacement until
Potassium
>3.5 meq/L
Serum Potassium
3.5 to 5.0 meq/L
Add 30-40 meq
Potassium
per liter to IV fluids
Serum Potassium
>5.0 meq/L
Do not administer any IV
Potassium
Monitor every 1 hour until <5.0 meq/L, then every 2-3 hours
Phosphate Replacement
Indications
Serum Phosphorus
< 0.5-1.0 mg/dl (Severe Depletion)
Controversial - May not be required
Consider if cardiopulmonary adverse affects
Contraindications
Renal Insufficiency
Administration
Determine
Potassium Replacement
as above
Replace part of
Potassium
with
Potassium
phosphate
Potassium
Phosphate: Replace one third
Potassium
Potassium
Chloride: Replace two thirds
Potassium
Magnesium Replacement
Indications
Symptomatic
Hypomagnesemia
(
Magnesium
<1 meq/L)
Administration
MgSO4 50%: 0.2 ml/kg/day IM divide in 3 doses
Sodium Bicarbonate
Replacement
Indications
Consider for ABG or VBG pH < 7.0 after initial hour of hydration
However, generally avoided as pH rapidly corrects with IV fluids and
Insulin
Other contributing factors
Shock
or
Coma
Severe
Hyperkalemia
Administration
See
Sodium Bicarbonate in Severe Metabolic Acidosis
Add 2 mEq/kg NaCl to NS for a final solution with no more than 155 mEq/L
Sodium
Administer solution over 1 hour
Management
Phase 3 -
Glucose
control in children
Initial
Insulin Dosing
Intravenous protocol
IV
Regular Insulin
drip starting at 0.1 unit/kg/hour
Subcutaneous protocol (if IV not available)
Bolus:
Regular Insulin
0.3 units/kg SC
Maintenance
Per 1 Hour: 0.1 units/kg or
Per 2 Hours: 0.15 to 0.20 units/kg
Alternative SQ
Insulin
Protocol for Mild to Moderate DKA (pH >7.2)
See Alternative
Glucose
Control Protocol in Children below
Maintenance
Continue
Insulin Infusion
until acidosis resolves
When pH>7.3 and serum bicarbonate >15 mEq/L
Decrease
Insulin Infusion
to 0.05 units/kg/hour
Continue
Insulin Infusion
until SC
Insulin
started
Glucose
and electolyte monitoring
Check bedside
Glucose
every 30 min to 2 hours until stable
Add dextrose to replacement fluids when
Serum Glucose
<250 mg/dl (see Fluids above)
Recheck basic metabolic panel every 2-4 hours until stable (see labs below)
Initiate subcutaneous
Insulin Dosing
Known diabetic
Restart prior program and readjust
Insulin
New patient: Determine
Insulin
requirements
Regular 0.1 to 0.25 units per kg
Regular Insulin
every 6-8 hours or
Divide 0.5 to 1 unit/kg/day into twice daily regimen of short and long acting
Insulin
AM (66%): Give 1/3 short acting and 2/3 intermediate to long actng
Insulin
PM (33%): Give 1/2 short acting and 1/2 intermediate to long actng
Insulin
Management
Phase 3b - Alternative SQ
Insulin
Protocol (Emergency Department)
Alternative SQ
Insulin
Protocol (to Phase 3a above) for Mild to Moderate DKA (pH >7.2)
Indications
Mild to Moderate DKA (pH >7.2) AND
Established diabetic patient with good follow-up
Able to tolerate oral intake
Approach
May be initiated in Emergency Department
Involve the patient's endocrinologist
Allow the patient to eat
Insulin
Give the patient's typical
Basal insulin
dose (e.g. night time
Lantus
or
Insulin Glargine
)
Give sliding scale
Insulin
coverage (e.g. units per
Carbohydrate
plus units per 50 over 150)
Monitoring
Perform hourly bedside
Glucose
Repeat pH and basic chemistry panel at 4 hours
Disposition
Admit patients with persistent
Metabolic Acidosis with Anion Gap
, or other complications
Indications to consider disposition home from emergency department after 4 hours
pH has normalized or near normalized (>7.25 or 7.3)
Normal
Anion Gap
References
Claudius, Behar and Rivera in Herbert (2021) EM:Rap 21(7): 2-4
Razavi (2018) Endocrine 61(2):267-74 +PMID: 29797212 [PubMed]
Management
Respiratory Failure
Similar to approach for adult DKA
Respiratory Failure
Indications for Intubation in DKA
Diabetic Ketoacidosis Related Cerebral Edema
Obtunded Mental Status
Avoid Intubation if possible
Peri-intubation apnea is poorly tolerated by the patient with severe
Metabolic Acidosis
(
Cardiac Arrest
risk)
High
Respiratory Rate
must be matched to allow facilitate acidosis correction (otherwise
Metabolic Acidosis
will worsen)
If intubation is unavoidable
Record
Respiratory Rate
prior to intubation
RSI with
Rocuronium
(avoid
Succinylcholine
due to
Hyperkalemia
)
Use
Intubation Preoxygenation
Leave patient on Bipap,
Ventilator
SIMV or
Bag Valve Mask
until time to insert
Laryngoscope
High flow nasal canula could be left in place throughout
Endotracheal Intubation
Optimize first pass success by the most experienced operator
Set
Ventilator
rate to preintubation
Respiratory Rate
(typically 30-40 breaths/min in severe DKA)
Post-intubation precautions:
Breath Stacking
(
Auto-PEEP
)
Breath Stacking
(
Auto-PEEP
) occurs with high
Ventilator
rates
Monitor repeat VBG or ABG
Check plateau pressure at time of inspiratory pause
Plateau pressure >30 mmHg should prompt disconnecting vent to allow for a full expiration
Decrease
Respiratory Rate
if
Breath Stacking
occurs
Monitoring
Labs and Exam every 2-4 hours until stable
Vital Sign
s and neurologic status
Serum
Electrolyte
s (including
Serum Potassium
and
Serum Sodium
)
Serum Creatinine
Venous Blood Gas
(VBG)
Serum Glucose
(checked every 30 min to hour as above)
Management
Disposition
Intensive Care
Unit (ICU) Indications
Severe DKA (e.g. pH <7.1)
Altered Mental Status
Abnormal
Electrolyte
s
Transfer to pediatric tertiary care for moderate to severe DKA
Use
Critical Care Transport
when available
References
Fahlsing and Ponce (2024) Crit Dec Emerg Med 38(3): 18-9
Brink (1999) Diabetes Nutr Metab 12:122-35 [PubMed]
Kitabchi (2001) Diabetes Care 24:131-53 [PubMed]
Kitabchi (2004) Diabetes Care 27(suppl 1): S94-102 [PubMed]
Trachtenbarg (2005) Am Fam Physician 71: 1705-22 [PubMed]
Tzimenatos (2021) Ann Emerg Med 78(3): 340-5 [PubMed]
Type your search phrase here